Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Lung Neoplasms

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldini, MT; Buraggi, GL; Cascinelli, N; Castellani, MR; Gasparini, M; Maffioli, L; Mascheroni, L; Mongioj, V; Seregni, E1

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Lung Neoplasms

ArticleYear
Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Benzamides; Contrast Media; Dopamine Antagonists; Evaluation Studies as Topic; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pyrrolidines; Radiation Dosage; Skin Neoplasms; Tomography, Emission-Computed, Single-Photon

1994